MLchartDataset catalogue

S-1

Term · Oncology and biomedicine · MLC-T-ONC-007527

A drug that is being studied for its ability to enhance the effectiveness of fluorouracil and prevent gastrointestinal side effects caused by fluorouracil. It belongs to the family of drugs called antimetabolites.

Table 1. Record
IdentifierMLC-T-ONC-007527
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007527",
  "term": "S-1",
  "field": "Oncology and biomedicine",
  "definition": "A drug that is being studied for its ability to enhance the effectiveness of fluorouracil and prevent gastrointestinal side effects caused by fluorouracil. It belongs to the family of drugs called antimetabolites.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/s-1/"
}

Record 14,628 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.